Cyclacel Pharmaceuticals Inc 6% Conv. Pref. Shrs (NASDAQ:CYCCP) Share Price Passes Below 200 Day Moving Average of $0.00

Cyclacel Pharmaceuticals Inc 6% Conv. Pref. Shrs (NASDAQ:CYCCP)’s stock price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.00 and traded as low as $5.46. Cyclacel Pharmaceuticals Inc 6% Conv. Pref. Shrs shares last traded at $5.50, with a volume of 434 shares traded.

The business has a fifty day moving average price of $5.14.

About Cyclacel Pharmaceuticals Inc 6% Conv. Pref. Shrs (NASDAQ:CYCCP)

Cyclacel Pharmaceuticals, Inc, a biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's oncology development programs include sapacitabine, a novel orally-available nucleoside analog that is in Phase III clinical trial for the front-line treatment of acute myeloid leukemia; and Phase II clinical trial for the treatment of myelodysplastic syndromes.

Further Reading: What are the components of an earnings report?

Receive News & Ratings for Cyclacel Pharmaceuticals Inc 6% Conv. Pref. Shrs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyclacel Pharmaceuticals Inc 6% Conv. Pref. Shrs and related companies with MarketBeat.com's FREE daily email newsletter.